
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
InhaTarget Therapeutics develops innovative and targeted dry powders for inhalation (DPI) that aim to improve the treatmentsof respiratory diseases, with a particular focus on lung cancer Capitalizing on its advanced expertise in pulmonary drug delivery (especially in DPI), InhaTarget Therapeutics organizes its activities under two strands: 1. The early development of proprietary products (phase I/II) to be licensed to pharmaceutical partners. InhaTarget therapeutics wants to focus on its core competencies (R&D and clinical proof-of concept) to deliver proven high-quality products to a pharma partner which will be in charge of the conduct of later clinical studies, regulatory approvals and marketing...
Dry powder for inhalation,lung cancer,inhaled treatments,early stage r&d,asthma,and copd
Inhatarget therapeutics operates in the Pharmaceutical manufacturing industry.
Inhatarget therapeutics's revenue is 11m - 100m
Inhatarget therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.